INTENS-DYS: Comparative Impact of Protocolized Management, Intensive Rehabilitation Versus Long-term Classic Rehabilitation of Dyslexic Children.

Sponsor
Centre Hospitalier Universitaire de Besancon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05383937
Collaborator
(none)
20
2
24

Study Details

Study Description

Brief Summary

Dyslexia is characterized by difficulties with accurate and/or fluent word recognition and by poor spelling and decoding abilities. In France, dyslexia is a public health disorder. Dyslexia is a real public health problem in France, affecting 6% of the general population. However, no clinical trial of a standardized rehabilitation has shown an impact on reading fluency. In the era of intensive rehabilitation, a new protocol based on the current data from the medical literature has been designed.

Condition or Disease Intervention/Treatment Phase
  • Other: Speech Therapy INTENS-DYS
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparative Impact of Protocolized Management, Intensive Rehabilitation Versus Long-term Classic Rehabilitation of Dyslexic Children.
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: intensive arm

The children included in this arm will receive two weeks of daily care during which two daily speech therapy sessions of one hour each will be performed. This will be done between M2 and M4 of inclusion in order to avoid potential measurement bias. These sessions will be carried out by a state-qualified speech therapist employed at the CRRF of Bregille. They will guide the intensive rehabilitation of dyslexic children by focusing the exercises on their main difficulties.

Other: Speech Therapy INTENS-DYS
During the six research month, children included in the intensive arm will benefit of two daily hours speech therapy during two weeks. Those one will be carried out between the second and the fourth month.

Active Comparator: classic arm or gold standard

The speech therapy session will be provided only by private practitioners, with a weekly consultation of 30 minutes. The private speech therapist who initially referred the patient for inclusion in the research protocol will be responsible for his or her "classic" rehabilitation. The therapy will continue during the 6 months of research.

Other: Speech Therapy INTENS-DYS
During the six research month, children included in the intensive arm will benefit of two daily hours speech therapy during two weeks. Those one will be carried out between the second and the fourth month.

Outcome Measures

Primary Outcome Measures

  1. Reading fluency to the Alouette test. [Six month.]

    Difference in the number of words read correctly in three minutes in the intensive and the conventional arm.

Secondary Outcome Measures

  1. Phonological processing tests. [Six month.]

    Difference in the number of errors in logatom repetition, which means phonological rules of a language corresponding of meaningless words, in the intensive and the conventional arm.

  2. Visual pattern. [Six month.]

    Difference in the number of errors to five visual pattern from the BALE and the EVALEO, in the intensive and the conventional arm.

  3. Life Quality. [6 month.]

    Difference on the AUQUEI self questionnary, in the intensive and the conventional arm.

  4. Rehabilitation adhesion. [6 month]

    Number of speech therapy session performed by patient in each arms.

  5. Speech langage rehabilitation cost. [6 month.]

    Differential cost/progress relation of intensive and classical rehabilitation.

  6. Family and school evaluation. [6 month.]

    Difference to Visual Analog Scale (VAS) regarding the benefit of speech therapy rehabilitation, assessed by the family and the school teachers, in each arms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children from 8 to 12 years old,

  • Living in and around 50 kilometers from Besançon.

  • Diagnosis of dyslexia according to the DSM-V or CIM-10 requirements.

  • Consent form signed by the parental authority and the child,

  • Affiliation to a social security system.

Exclusion Criteria:
  • Mother's medical history of pregnancy or delivery complications,

  • Patients's medical history of neurological infectious, vascular or tumoral events,

  • Patient's medical history of intellectual deficiency,

  • Patients's medical history of visual or hearing disorders,

  • Patient's medical history of psychiatric disorders (especially diagnosis of Attention Deficit / Hyperactivity Disorders (AD/HD)),

  • legal incapacity,

  • limited cooperation suspected by the investigator.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Besancon

Investigators

  • Principal Investigator: Julien BEVALOT, CHU de Besançon

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier:
NCT05383937
Other Study ID Numbers:
  • 2022/692
First Posted:
May 20, 2022
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Besancon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2022